Novel Pharmacological Strategies in the Treatment and Prevention of Acute Ischemic Stroke
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".
Deadline for manuscript submissions: closed (30 November 2023) | Viewed by 3866
Special Issue Editors
Interests: Alzheimer's disease; neurodegeneration; vascular disease; acute care; critically ill patient
Special Issues, Collections and Topics in MDPI journals
Interests: stroke; cognitive impairment; dementia; carotid ultrasound; migraine; headache
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
In recent years, treatment of acute ischemic stroke has seen a significant improvement thanks to both pharmacological and technological developments. Patients benefited greatly from an overall improvement in preventive strategies with newer anti-hypertensive and lipid-lowering drugs, direct oral anticoagulants, and more effective antiplatelet regimens that reduced the number of severe ischemic strokes. Moreover, newer combined strategies, such as fibrinolysis with sequential thrombectomy performed by better defining damaged areas with perfusion CT scan or MRI, resulted in overall improved functional outcomes.
In this Special Issue, we are interested in basic and translational research papers regarding the physiological, molecular, and clinical effects of newer pharmacological approaches in the context of preventive strategies or treatment of acute ischemic stroke. Both original articles and review papers will be considered for publication in this Special Issue of Biomedicines.
Dr. Lorenzo Falsetti
Dr. Giovanna Viticchi
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
